The case against routine preoperative breast MRI

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Jatoi I. Options in breast cancer local therapy: who gets what? World J. Surg.36,1498–1502 (2012).▪ Discusses the various local therapy options in breast cancer.
  MedlineGoogle Scholar
• 2  Kumar A, Puri R, Gadgil PV et al. Sentinel lymph node biopsy in primary breast cancer: window to management of the axilla. World J. Surg.36,1453–1459 (2012).
  MedlineGoogle Scholar
• 3  Veronesi U, Bonadonna G, Zurrida S et al. Conservation surgery after primary chemotherapy in large carcinomas of the breast. Ann. Surg.222,612–618 (1995).
  Medline CASGoogle Scholar
• 4  van Sprundel TC, Schmidt MK, Rookus MA et al. Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br. J. Cancer93,287–292 (2005).
  Medline CASGoogle Scholar
• 5  Fowble B, Yeh IT, Schultz DJ et al. The role of mastectomy in patients with stage I-II breast cancer presenting with gross multifocal or multicentric disease or diffuse microcalcifications. Int. J. Radiat. Oncol. Biol. Phys.27,567–573 (1993).
  Medline CASGoogle Scholar
• 6  Morrow M, Waters J, Morris E. MRI for breast cancer screening, diagnosis, and treatment. Lancet378,1804–2011 (1811).▪▪ Excellent surgical perspective on the overall issue of breast MRI.
  Google Scholar
• 7  Plana MN, Carreira C, Muriel A et al. Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis. Eur. Radiol.22,26–38 (2012).
  MedlineGoogle Scholar
• 8  Qualheim RE, Gall EA. Breast carcinoma with multiple sites of origin. Cancer10,460–468 (1957).
  Medline CASGoogle Scholar
• 9  Fisher ER, Gregorio R, Redmond C et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). I. Observations concerning the multicentricity of mammary cancer. Cancer35,247–254 (1975).
  Medline CASGoogle Scholar
• 10  Holland R, Veling SH, Mravunac M et al. Histologic multifocality of Tis, T1–2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer56,979–990 (1985).
  Medline CASGoogle Scholar
• 11  Vaidya JS, Vyas JJ, Chinoy RF et al. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br. J. Cancer74,820–824 (1996).▪▪ Very important study confirming the multicentricity of breast cancer.
  Medline CASGoogle Scholar
• 12  Sharpe CR. A developmental hypothesis to explain the multicentricity of breast cancer. CMAJ159,55–59 (1998).
  Medline CASGoogle Scholar
• 13  Jatoi I, Proschan MA. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am. J. Clin. Oncol.28,289–294 (2005).▪ Meta-analysis of the six randomized trials comparing mastectomy with breast-conserving surgery, undertaken prior to the availability of breast MRI.
  MedlineGoogle Scholar
• 14  Morrow M, Harris JR, Schnitt SJ. Surgical margins in lumpectomy for breast cancer – bigger is not better. N. Engl. J. Med.367,79–82 (2012).▪ Important viewpoint summarizing the role of systemic therapy in the treatment of occult breast cancer.
  MedlineGoogle Scholar
• 15  Darby S, McGale P, Correa C et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet378,1707–1716 (2011).
  Medline CASGoogle Scholar
• 16  Lonning PE. Treatment of early breast cancer with conservation of the breast. A review. Acta Oncol.30,779–792 (1991).
  Medline CASGoogle Scholar
• 17  Ciatto S, Bernardi D. Is preoperative staging with breast MRI causing overtreatment with mastectomies? Womens Health (Lond. Engl.)8,119–122 (2012).
  MedlineGoogle Scholar
• 18  Lehman CD, Gatsonis C, Kuhl CK et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N. Engl. J. Med.356,1295–1303 (2007).
  Medline CASGoogle Scholar
• 19  Sardanelli F. Overview of the role of preoperative breast MRI in the absence of evidence on patient outcomes. Breast19,3–6 (2010).
  MedlineGoogle Scholar
• 20  Fischer U, Zachariae O, Baum F et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur. Radiol.14,1725–1731 (2004).
  MedlineGoogle Scholar
• 21  Solin LJ, Orel SG, Hwang WT et al. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J. Clin. Oncol.26,386–391 (2008).
  MedlineGoogle Scholar
• 22  Houssami N, Hayes DF. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J. Clin.59,290–302 (2009).▪▪ Excellent review on this topic.
  MedlineGoogle Scholar
• 23  Turnbull L, Brown S, Harvey I et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet375,563–571 (2010).
  MedlineGoogle Scholar
• 24  Peters NH, van Esser S, van den Bosch MA et al. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET – randomised controlled trial. Eur. J. Cancer47,879–886 (2011).
  Medline CASGoogle Scholar
• 25  Hwang N, Schiller DE, Crystal P et al. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Ann. Surg.Oncol.16,3000–3009 (2009).
  Google Scholar
• 26  Mann RM, Loo CE, Wobbes T et al. The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res. Treat.119,415–422 (2010).
  Medline CASGoogle Scholar
• 27  Mann RM, Boetes C. MRI for breast conservation surgery. Lancet375,2213 (2010).
  Medline CASGoogle Scholar
• 28  Houssami N, Ciatto S, Macaskill P et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J. Clin. Oncol.26,3248–3258 (2008).▪▪ Important meta-analysis on this topic.
  MedlineGoogle Scholar
• 29  Jeevan R, Cromwell DA, Trivella M et al. Reoperation rates after breast-conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics. BMJ345,e4505 (2012).
  Medline CASGoogle Scholar
• 30  Morrow M, Jagsi R, Alderman AK et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA302,1551–1556 (2009).
  Medline CASGoogle Scholar
• 31  Katipamula R, Degnim AC, Hoskin T et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J. Clin. Oncol.27,4082–4088 (2009).
  MedlineGoogle Scholar
• 32  Habermann EB, Abbott A, Parsons HM et al. Are mastectomy rates really increasing in the United States? J. Clin. Oncol.28,3437–3441 (2010).
  MedlineGoogle Scholar
• 33  Mameri CS, Kemp C, Goldman SM et al. Impact of breast MRI on surgical treatment, axillary approach, and systemic therapy for breast cancer. Breast J.14,236–244 (2008).
  MedlineGoogle Scholar
• 34  Morrow M, Freedman G. A clinical oncology perspective on the use of breast MR. Magn. Reson. Imaging Clin. N. Am.14,363–378, VI (2006).
  MedlineGoogle Scholar
• 35  Orel S. Who should have breast magnetic resonance imaging evaluation? J. Clin. Oncol.26,703–711 (2008).
  MedlineGoogle Scholar
• 36  Saslow D, Boetes C, Burke W et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J. Clin.57,75–89 (2007).
  MedlineGoogle Scholar
• 37  Jatoi I, Anderson WF. Management of women who have a genetic predisposition for breast cancer. Surg. Clin. North. Am.88,845–861 (2008).
  MedlineGoogle Scholar
• 38  Vaidya JS, Baum M. Benefits and risks of screening mammography in women with BRCA1 and BRCA2 mutations. JAMA278,290 (1997).
  Medline CASGoogle Scholar
• 39  Orel SG, Weinstein SP, Schnall MD et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology212,543–549 (1999).
  Medline CASGoogle Scholar
• 40  Nakahara H, Namba K, Watanabe R et al. A comparison of MR imaging, galactography and ultrasonography in patients with nipple discharge. Breast Cancer10,320–329 (2003).
  MedlineGoogle Scholar
• 41  Mann RM, Kuhl CK, Kinkel K et al. Breast MRI: guidelines from the European Society of Breast Imaging. Eur. Radiol.18,1307–1318 (2008).
  Medline CASGoogle Scholar